Divergência genética entre quinze acessos de aceroleira com base em marcadores RAPD.

A acerola (Malpighia emarginata L.) é uma frutífera tropical, originária das Antilhas, que encontrou no Brasil condições favoráveis ao seu cultivo comercial, sendo de grande importância econômica e social devido ao seu alto conteúdo de ácido ascórbico (vitamina C) (GONZAGA NETO et aI., 1995; RITZINGER et aI., 2003; SALLA et aI., 2002). Apesar da sua importância social e do seu elevado potencial econômico, muito pouco tem sido feito para o conhecimento e uso dessa espécie, seja na área de coleta, conservação, caracterização e avaliação de germoplasma, seja no melhoramento genético visando o desenvolvimento de cultivares ou de práticas adequadas de cultivo e manejo (GONZAGA NETO et aI., 1995; PAIVA et aI., 2001; RITZINGER et aI., 2003; SALLA et aI., 2002). As variedades de aceroleira atualmente plantadas no Brasil apresentam produtividade e qualidade de frutos baixos, especialmente para a indústria de processamento, fato que aliado à prática ainda comum de plantio de mudas obtidas por sementes, traz prejuízos para o agricultor (SALLA et aI., 2002). Em razão disso, a preservação da variabilidade genética da aceroleira, mediante a constituição de bancos de germoplasma, tem grande importância tanto do ponto de vista da conservação biológica como da aplicação no melhoramento genético. A cultura da aceroleira apresenta grandes carências quanto à informação molecular, que poderá ser suprida com o emprego destes marcadores. O presente estudo teve por finalidade avaliar a divergência genética entre 15 acessos de aceroleira, pertencentes ao Banco Ativo de Germoplasma da Embrapa Mandioca e Fruticultura Tropical, através cinco primers, usando marcadores RAPD (Random Amplified Polymorphic DNA).pdf 120

Clasificación microscópica de las lesiones cutáneas producidas por Hypoderma lineatum

Trabajo presentado a la: XXVII Reunión de la Sociedad Española de Anatomía Patológica Veterinaria. (Barcelona, España, 17 al 19 Junio, 2015).Peer Reviewe

Rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART): study protocol for a randomized controlled trial

BACKGROUND: Acute respiratory distress syndrome (ARDS) is associated with high in-hospital mortality. Alveolar recruitment followed by ventilation at optimal titrated PEEP may reduce ventilator-induced lung injury and improve oxygenation in patients with ARDS, but the effects on mortality and other clinical outcomes remain unknown. This article reports the rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART). METHODS/DESIGN: ART is a pragmatic, multicenter, randomized (concealed), controlled trial, which aims to determine if maximum stepwise alveolar recruitment associated with PEEP titration is able to increase 28-day survival in patients with ARDS compared to conventional treatment (ARDSNet strategy). We will enroll adult patients with ARDS of less than 72 h duration. The intervention group will receive an alveolar recruitment maneuver, with stepwise increases of PEEP achieving 45 cmH2O and peak pressure of 60 cmH2O, followed by ventilation with optimal PEEP titrated according to the static compliance of the respiratory system. In the control group, mechanical ventilation will follow a conventional protocol (ARDSNet). In both groups, we will use controlled volume mode with low tidal volumes (4 to 6 mL/kg of predicted body weight) and targeting plateau pressure 6430 cmH2O. The primary outcome is 28-day survival, and the secondary outcomes are: length of ICU stay; length of hospital stay; pneumothorax requiring chest tube during first 7 days; barotrauma during first 7 days; mechanical ventilation-free days from days 1 to 28; ICU, in-hospital, and 6-month survival. ART is an event-guided trial planned to last until 520 events (deaths within 28 days) are observed. These events allow detection of a hazard ratio of 0.75, with 90% power and two-tailed type I error of 5%. All analysis will follow the intention-to-treat principle. DISCUSSION: If the ART strategy with maximum recruitment and PEEP titration improves 28-day survival, this will represent a notable advance to the care of ARDS patients. Conversely, if the ART strategy is similar or inferior to the current evidence-based strategy (ARDSNet), this should also change current practice as many institutions routinely employ recruitment maneuvers and set PEEP levels according to some titration metho

Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study

Background Early death after cancer surgery is higher in low-income and middle-income countries (LMICs) compared with in high-income countries, yet the impact of facility characteristics on early postoperative outcomes is unknown. The aim of this study was to examine the association between hospital infrastructure, resource availability, and processes on early outcomes after cancer surgery worldwide.Methods A multimethods analysis was performed as part of the GlobalSurg 3 study-a multicentre, international, prospective cohort study of patients who had surgery for breast, colorectal, or gastric cancer. The primary outcomes were 30-day mortality and 30-day major complication rates. Potentially beneficial hospital facilities were identified by variable selection to select those associated with 30-day mortality. Adjusted outcomes were determined using generalised estimating equations to account for patient characteristics and country-income group, with population stratification by hospital.Findings Between April 1, 2018, and April 23, 2019, facility-level data were collected for 9685 patients across 238 hospitals in 66 countries (91 hospitals in 20 high-income countries; 57 hospitals in 19 upper-middle-income countries; and 90 hospitals in 27 low-income to lower-middle-income countries). The availability of five hospital facilities was inversely associated with mortality: ultrasound, CT scanner, critical care unit, opioid analgesia, and oncologist. After adjustment for case-mix and country income group, hospitals with three or fewer of these facilities (62 hospitals, 1294 patients) had higher mortality compared with those with four or five (adjusted odds ratio [OR] 3.85 [95% CI 2.58-5.75]; p<0.0001), with excess mortality predominantly explained by a limited capacity to rescue following the development of major complications (63.0% vs 82.7%; OR 0.35 [0.23-0.53]; p<0.0001). Across LMICs, improvements in hospital facilities would prevent one to three deaths for every 100 patients undergoing surgery for cancer.Interpretation Hospitals with higher levels of infrastructure and resources have better outcomes after cancer surgery, independent of country income. Without urgent strengthening of hospital infrastructure and resources, the reductions in cancer-associated mortality associated with improved access will not be realised

Rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART): Study protocol for a randomized controlled trial

Background: Acute respiratory distress syndrome (ARDS) is associated with high in-hospital mortality. Alveolar recruitment followed by ventilation at optimal titrated PEEP may reduce ventilator-induced lung injury and improve oxygenation in patients with ARDS, but the effects on mortality and other clinical outcomes remain unknown. This article reports the rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART). Methods/Design: ART is a pragmatic, multicenter, randomized (concealed), controlled trial, which aims to determine if maximum stepwise alveolar recruitment associated with PEEP titration is able to increase 28-day survival in patients with ARDS compared to conventional treatment (ARDSNet strategy). We will enroll adult patients with ARDS of less than 72 h duration. The intervention group will receive an alveolar recruitment maneuver, with stepwise increases of PEEP achieving 45 cmH(2)O and peak pressure of 60 cmH2O, followed by ventilation with optimal PEEP titrated according to the static compliance of the respiratory system. In the control group, mechanical ventilation will follow a conventional protocol (ARDSNet). In both groups, we will use controlled volume mode with low tidal volumes (4 to 6 mL/kg of predicted body weight) and targeting plateau pressure <= 30 cmH2O. The primary outcome is 28-day survival, and the secondary outcomes are: length of ICU stay; length of hospital stay; pneumothorax requiring chest tube during first 7 days; barotrauma during first 7 days; mechanical ventilation-free days from days 1 to 28; ICU, in-hospital, and 6-month survival. ART is an event-guided trial planned to last until 520 events (deaths within 28 days) are observed. These events allow detection of a hazard ratio of 0.75, with 90% power and two-tailed type I error of 5%. All analysis will follow the intention-to-treat principle. Discussion: If the ART strategy with maximum recruitment and PEEP titration improves 28-day survival, this will represent a notable advance to the care of ARDS patients. Conversely, if the ART strategy is similar or inferior to the current evidence-based strategy (ARDSNet), this should also change current practice as many institutions routinely employ recruitment maneuvers and set PEEP levels according to some titration method.Hospital do Coracao (HCor) as part of the Program 'Hospitais de Excelencia a Servico do SUS (PROADI-SUS)'Brazilian Ministry of Healt

An allele of Arabidopsis COI1 with hypo- and hypermorphic phenotypes in plant growth, defence and fertility

Resistance to biotrophic pathogens is largely dependent on the hormone salicylic acid (SA) while jasmonic acid (JA) regulates resistance against necrotrophs. JA negatively regulates SA and is, in itself, negatively regulated by SA. A key component of the JA signal transduction pathway is its receptor, the COI1 gene. Mutations in this gene can affect all the JA phenotypes, whereas mutations in other genes, either in JA signal transduction or in JA biosynthesis, lack this general effect. To identify components of the part of the resistance against biotrophs independent of SA, a mutagenised population of NahG plants (severely depleted of SA) was screened for suppression of susceptibility. The screen resulted in the identification of intragenic and extragenic suppressors, and the results presented here correspond to the characterization of one extragenic suppressor, coi1-40. coi1-40 is quite different from previously described coi1 alleles, and it represents a strategy for enhancing resistance to biotrophs with low levels of SA, likely suppressing NahG by increasing the perception to the remaining SA. The phenotypes of coi1-40 lead us to speculate about a modular function for COI1, since we have recovered a mutation in COI1 which has a number of JA-related phenotypes reduced while others are equal to or above wild type levels.This work was supported by grant BIO201018896 from "Ministerio de Economia y Competitividad" (MINECO) of Spain and by grant ACOMP/2012/105 from "Generalitat Valenciana" to PT, a JAE-CSIC Fellowship to JVC, a FPI-MINECO to AD, and Fellowships from the European Molecular Biology Organization and the Human Frontier Science Program to BBHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Dobón Alonso, A.; Wulff, BBH.; Canet Perez, JV.; Fort Rausell, P.; Tornero Feliciano, P. (2013). An allele of Arabidopsis COI1 with hypo- and hypermorphic phenotypes in plant growth, defence and fertility. PLoS ONE. 1(8):55115-55115. https://doi.org/10.1371/journal.pone.0055115S551155511518Vlot, A. C., Dempsey, D. A., & Klessig, D. F. (2009). Salicylic Acid, a Multifaceted Hormone to Combat Disease. Annual Review of Phytopathology, 47(1), 177-206. doi:10.1146/annurev.phyto.050908.135202Mauch, F., Mauch-Mani, B., Gaille, C., Kull, B., Haas, D., & Reimmann, C. (2001). Manipulation of salicylate content in Arabidopsis thaliana by the expression of an engineered bacterial salicylate synthase. The Plant Journal, 25(1), 67-77. doi:10.1046/j.1365-313x.2001.00940.xGaffney, T., Friedrich, L., Vernooij, B., Negrotto, D., Nye, G., Uknes, S., … Ryals, J. (1993). Requirement of Salicylic Acid for the Induction of Systemic Acquired Resistance. Science, 261(5122), 754-756. doi:10.1126/science.261.5122.754Delaney, T. P., Uknes, S., Vernooij, B., Friedrich, L., Weymann, K., Negrotto, D., … Ryals, J. (1994). A Central Role of Salicylic Acid in Plant Disease Resistance. Science, 266(5188), 1247-1250. doi:10.1126/science.266.5188.1247Lawton, K. (1995). Systemic Acquired Resistance inArabidopsisRequires Salicylic Acid but Not Ethylene. Molecular Plant-Microbe Interactions, 8(6), 863. doi:10.1094/mpmi-8-0863Ross, A. F. (1961). Systemic acquired resistance induced by localized virus infections in plants. Virology, 14(3), 340-358. doi:10.1016/0042-6822(61)90319-1Pieterse, C. M. ., & van Loon, L. C. (1999). Salicylic acid-independent plant defence pathways. Trends in Plant Science, 4(2), 52-58. doi:10.1016/s1360-1385(98)01364-8Fonseca, S., Chico, J. M., & Solano, R. (2009). The jasmonate pathway: the ligand, the receptor and the core signalling module. Current Opinion in Plant Biology, 12(5), 539-547. doi:10.1016/j.pbi.2009.07.013Ton, J., De Vos, M., Robben, C., Buchala, A., Métraux, J.-P., Van Loon, L. C., & Pieterse, C. M. J. (2002). Characterization ofArabidopsisenhanced disease susceptibility mutants that are affected in systemically induced resistance. The Plant Journal, 29(1), 11-21. doi:10.1046/j.1365-313x.2002.01190.xCui, J., Bahrami, A. K., Pringle, E. G., Hernandez-Guzman, G., Bender, C. L., Pierce, N. E., & Ausubel, F. M. (2005). Pseudomonas syringae manipulates systemic plant defenses against pathogens and herbivores. Proceedings of the National Academy of Sciences, 102(5), 1791-1796. doi:10.1073/pnas.0409450102Robert-Seilaniantz, A., Navarro, L., Bari, R., & Jones, J. D. (2007). Pathological hormone imbalances. Current Opinion in Plant Biology, 10(4), 372-379. doi:10.1016/j.pbi.2007.06.003Garcion, C., Lohmann, A., Lamodière, E., Catinot, J., Buchala, A., Doermann, P., & Métraux, J.-P. (2008). Characterization and Biological Function of the ISOCHORISMATE SYNTHASE2 Gene of Arabidopsis. Plant Physiology, 147(3), 1279-1287. doi:10.1104/pp.108.119420Tornero, P., Chao, R. A., Luthin, W. N., Goff, S. A., & Dangl, J. L. (2002). Large-Scale Structure –Function Analysis of the Arabidopsis RPM1 Disease Resistance Protein. The Plant Cell, 14(2), 435-450. doi:10.1105/tpc.010393Bowling, S. A., Guo, A., Cao, H., Gordon, A. S., Klessig, D. F., & Dong, X. (1994). A mutation in Arabidopsis that leads to constitutive expression of systemic acquired resistance. The Plant Cell, 6(12), 1845-1857. doi:10.1105/tpc.6.12.1845Bowling, S. A., Clarke, J. D., Liu, Y., Klessig, D. F., & Dong, X. (1997). The cpr5 mutant of Arabidopsis expresses both NPR1-dependent and NPR1-independent resistance. The Plant Cell, 9(9), 1573-1584. doi:10.1105/tpc.9.9.1573Yu, I. -c., Parker, J., & Bent, A. F. (1998). Gene-for-gene disease resistance without the hypersensitive response in Arabidopsis dnd1 mutant. Proceedings of the National Academy of Sciences, 95(13), 7819-7824. doi:10.1073/pnas.95.13.7819Dietrich, R. A., Delaney, T. P., Uknes, S. J., Ward, E. R., Ryals, J. A., & Dangl, J. L. (1994). Arabidopsis mutants simulating disease resistance response. Cell, 77(4), 565-577. doi:10.1016/0092-8674(94)90218-6Rivas-San Vicente, M., & Plasencia, J. (2011). Salicylic acid beyond defence: its role in plant growth and development. Journal of Experimental Botany, 62(10), 3321-3338. doi:10.1093/jxb/err031Wang, D. (2005). Induction of Protein Secretory Pathway Is Required for Systemic Acquired Resistance. Science, 308(5724), 1036-1040. doi:10.1126/science.1108791Ritter, C. (1995). TheavrRpm1Gene ofPseudomonas syringaepv.maculicolaIs Required for Virulence on Arabidopsis. Molecular Plant-Microbe Interactions, 8(3), 444. doi:10.1094/mpmi-8-0444Debener, T., Lehnackers, H., Arnold, M., & Dangl, J. L. (1991). Identification and molecular mapping of a single Arabidopsis thaliana locus determining resistance to a phytopathogenic Pseudomonas syringae isolate. The Plant Journal, 1(3), 289-302. doi:10.1046/j.1365-313x.1991.t01-7-00999.xGrant, M., Godiard, L., Straube, E., Ashfield, T., Lewald, J., Sattler, A., … Dangl, J. (1995). Structure of the Arabidopsis RPM1 gene enabling dual specificity disease resistance. Science, 269(5225), 843-846. doi:10.1126/science.7638602Mindrinos, M., Katagiri, F., Yu, G.-L., & Ausubel, F. M. (1994). The A. thaliana disease resistance gene RPS2 encodes a protein containing a nucleotide-binding site and leucine-rich repeats. Cell, 78(6), 1089-1099. doi:10.1016/0092-8674(94)90282-8Coego, A., Ramirez, V., Gil, M. J., Flors, V., Mauch-Mani, B., & Vera, P. (2005). An Arabidopsis Homeodomain Transcription Factor, OVEREXPRESSOR OF CATIONIC PEROXIDASE 3, Mediates Resistance to Infection by Necrotrophic Pathogens. The Plant Cell, 17(7), 2123-2137. doi:10.1105/tpc.105.032375Pieterse, C. M. J., van Wees, S. C. M., van Pelt, J. A., Knoester, M., Laan, R., Gerrits, H., … van Loon, L. C. (1998). A Novel Signaling Pathway Controlling Induced Systemic Resistance in Arabidopsis. The Plant Cell, 10(9), 1571-1580. doi:10.1105/tpc.10.9.1571Berger, S., Bell, E., & Mullet, J. E. (1996). Two Methyl Jasmonate-Insensitive Mutants Show Altered Expression of AtVsp in Response to Methyl Jasmonate and Wounding. Plant Physiology, 111(2), 525-531. doi:10.1104/pp.111.2.525Attaran, E., Zeier, T. E., Griebel, T., & Zeier, J. (2009). Methyl Salicylate Production and Jasmonate Signaling Are Not Essential for Systemic Acquired Resistance in Arabidopsis. The Plant Cell, 21(3), 954-971. doi:10.1105/tpc.108.063164Yan, J., Zhang, C., Gu, M., Bai, Z., Zhang, W., Qi, T., … Xie, D. (2009). The Arabidopsis CORONATINE INSENSITIVE1 Protein Is a Jasmonate Receptor. The Plant Cell, 21(8), 2220-2236. doi:10.1105/tpc.109.065730Mittal, S. (1995). Role of the Phytotoxin Coronatine in the Infection ofAmbidopsis thalianabyPseudomonas syringaepv.tomato. Molecular Plant-Microbe Interactions, 8(1), 165. doi:10.1094/mpmi-8-0165Genoud, T., & Métraux, J.-P. (1999). Crosstalk in plant cell signaling: structure and function of the genetic network. Trends in Plant Science, 4(12), 503-507. doi:10.1016/s1360-1385(99)01498-3Lawton, K. A., Friedrich, L., Hunt, M., Weymann, K., Delaney, T., Kessmann, H., … Ryals, J. (1996). Benzothiadiazole induces disease resistance in Arabidopsis by activation of the systemic acquired resistance signal transduction pathway. The Plant Journal, 10(1), 71-82. doi:10.1046/j.1365-313x.1996.10010071.xFeys, B., Benedetti, C. E., Penfold, C. N., & Turner, J. G. (1994). Arabidopsis Mutants Selected for Resistance to the Phytotoxin Coronatine Are Male Sterile, Insensitive to Methyl Jasmonate, and Resistant to a Bacterial Pathogen. The Plant Cell, 751-759. doi:10.1105/tpc.6.5.751Sun, J., Xu, Y., Ye, S., Jiang, H., Chen, Q., Liu, F., … Li, C. (2009). Arabidopsis ASA1 Is Important for Jasmonate-Mediated Regulation of Auxin Biosynthesis and Transport during Lateral Root Formation. The Plant Cell, 21(5), 1495-1511. doi:10.1105/tpc.108.064303He, Y., Fukushige, H., Hildebrand, D. F., & Gan, S. (2002). Evidence Supporting a Role of Jasmonic Acid in Arabidopsis Leaf Senescence. Plant Physiology, 128(3), 876-884. doi:10.1104/pp.010843Shan, X., Zhang, Y., Peng, W., Wang, Z., & Xie, D. (2009). Molecular mechanism for jasmonate-induction of anthocyanin accumulation in Arabidopsis. Journal of Experimental Botany, 60(13), 3849-3860. doi:10.1093/jxb/erp223Yoshida, Y., Sano, R., Wada, T., Takabayashi, J., & Okada, K. (2009). Jasmonic acid control of GLABRA3 links inducible defense and trichome patterning in Arabidopsis. Development, 136(6), 1039-1048. doi:10.1242/dev.030585Borevitz, J. O., Xia, Y., Blount, J., Dixon, R. A., & Lamb, C. (2000). Activation Tagging Identifies a Conserved MYB Regulator of Phenylpropanoid Biosynthesis. The Plant Cell, 12(12), 2383-2393. doi:10.1105/tpc.12.12.2383Berger, S., Bell, E., Sadka, A., & Mullet, J. E. (1995). Arabidopsis thaliana Atvsp is homologous to soybean VspA and VspB, genes encoding vegetative storage protein acid phosphatases, and is regulated similarly by methyl jasmonate, wounding, sugars, light and phosphate. Plant Molecular Biology, 27(5), 933-942. doi:10.1007/bf00037021Feng, S., Ma, L., Wang, X., Xie, D., Dinesh-Kumar, S. P., Wei, N., & Deng, X. W. (2003). The COP9 Signalosome Interacts Physically with SCFCOI1 and Modulates Jasmonate Responses. The Plant Cell, 15(5), 1083-1094. doi:10.1105/tpc.010207Nawrath C, Métraux JP, Genoud T (2005) Chemical signals in plant resistance: salicylic acid. . In: Tuzun S, Bent E, editors. Multigenic and Induced Systemic Resistance in Plants. Dordrecht, Netherlands.: Springer US. pp. pp. 143–165.Kunkel, B. N., & Brooks, D. M. (2002). Cross talk between signaling pathways in pathogen defense. Current Opinion in Plant Biology, 5(4), 325-331. doi:10.1016/s1369-5266(02)00275-3Truman, W., Bennett, M. H., Kubigsteltig, I., Turnbull, C., & Grant, M. (2007). Arabidopsissystemic immunity uses conserved defense signaling pathways and is mediated by jasmonates. Proceedings of the National Academy of Sciences, 104(3), 1075-1080. doi:10.1073/pnas.0605423104Canet, J. V., Dobón, A., Ibáñez, F., Perales, L., & Tornero, P. (2010). Resistance and biomass in Arabidopsis: a new model for Salicylic Acid perception. Plant Biotechnology Journal, 8(2), 126-141. doi:10.1111/j.1467-7652.2009.00468.xCasimiro, I., Marchant, A., Bhalerao, R. P., Beeckman, T., Dhooge, S., Swarup, R., … Bennett, M. (2001). Auxin Transport Promotes Arabidopsis Lateral Root Initiation. The Plant Cell, 13(4), 843-852. doi:10.1105/tpc.13.4.843Celenza, J. L., Grisafi, P. L., & Fink, G. R. (1995). A pathway for lateral root formation in Arabidopsis thaliana. Genes & Development, 9(17), 2131-2142. doi:10.1101/gad.9.17.2131Traw, M. B., & Bergelson, J. (2003). Interactive Effects of Jasmonic Acid, Salicylic Acid, and Gibberellin on Induction of Trichomes in Arabidopsis. Plant Physiology, 133(3), 1367-1375. doi:10.1104/pp.103.027086Kloek, A. P., Verbsky, M. L., Sharma, S. B., Schoelz, J. E., Vogel, J., Klessig, D. F., & Kunkel, B. N. (2001). Resistance to Pseudomonas syringae conferred by an Arabidopsis thaliana coronatine-insensitive (coi1) mutation occurs through two distinct mechanisms. The Plant Journal, 26(5), 509-522. doi:10.1046/j.1365-313x.2001.01050.xXie, D. (1998). COI1: An Arabidopsis Gene Required for Jasmonate-Regulated Defense and Fertility. Science, 280(5366), 1091-1094. doi:10.1126/science.280.5366.1091Ellis, C., & Turner, J. (2002). A conditionally fertile coi1 allele indicates cross-talk between plant hormone signalling pathways in Arabidopsis thaliana seeds and young seedlings. Planta, 215(4), 549-556. doi:10.1007/s00425-002-0787-4Fernández-Arbaizar, A., Regalado, J. J., & Lorenzo, O. (2011). Isolation and Characterization of Novel Mutant Loci Suppressing the ABA Hypersensitivity of the Arabidopsis coronatine insensitive 1-16 (coi1-16) Mutant During Germination and Seedling Growth. Plant and Cell Physiology, 53(1), 53-63. doi:10.1093/pcp/pcr174He, Y., Chung, E.-H., Hubert, D. A., Tornero, P., & Dangl, J. L. (2012). Specific Missense Alleles of the Arabidopsis Jasmonic Acid Co-Receptor COI1 Regulate Innate Immune Receptor Accumulation and Function. PLoS Genetics, 8(10), e1003018. doi:10.1371/journal.pgen.1003018Xu, L., Liu, F., Lechner, E., Genschik, P., Crosby, W. L., Ma, H., … Xie, D. (2002). The SCFCOI1 Ubiquitin-Ligase Complexes Are Required for Jasmonate Response in Arabidopsis. The Plant Cell, 14(8), 1919-1935. doi:10.1105/tpc.003368Chini, A., Fonseca, S., Fernández, G., Adie, B., Chico, J. M., Lorenzo, O., … Solano, R. (2007). The JAZ family of repressors is the missing link in jasmonate signalling. Nature, 448(7154), 666-671. doi:10.1038/nature06006Grunewald, W., Vanholme, B., Pauwels, L., Plovie, E., Inzé, D., Gheysen, G., & Goossens, A. (2009). Expression of the Arabidopsis jasmonate signalling repressor JAZ1/TIFY10A is stimulated by auxin. EMBO reports, 10(8), 923-928. doi:10.1038/embor.2009.103Cao, H., Glazebrook, J., Clarke, J. D., Volko, S., & Dong, X. (1997). The Arabidopsis NPR1 Gene That Controls Systemic Acquired Resistance Encodes a Novel Protein Containing Ankyrin Repeats. Cell, 88(1), 57-63. doi:10.1016/s0092-8674(00)81858-9Century, K. S., Holub, E. B., & Staskawicz, B. J. (1995). NDR1, a locus of Arabidopsis thaliana that is required for disease resistance to both a bacterial and a fungal pathogen. Proceedings of the National Academy of Sciences, 92(14), 6597-6601. doi:10.1073/pnas.92.14.6597Wildermuth, M. C., Dewdney, J., Wu, G., & Ausubel, F. M. (2001). Isochorismate synthase is required to synthesize salicylic acid for plant defence. Nature, 414(6863), 562-565. doi:10.1038/35107108Lu, M., Tang, X., & Zhou, J.-M. (2001). Arabidopsis NHO1 Is Required for General Resistance against Pseudomonas Bacteria. The Plant Cell, 13(2), 437-447. doi:10.1105/tpc.13.2.437Ritter, C., & Dangl, J. L. (1996). Interference between Two Specific Pathogen Recognition Events Mediated by Distinct Plant Disease Resistance Genes. The Plant Cell, 251-257. doi:10.1105/tpc.8.2.251Tornero, P., & Dangl, J. L. (2002). A high-throughput method for quantifying growth of phytopathogenic bacteria in Arabidopsis thaliana. The Plant Journal, 28(4), 475-481. doi:10.1046/j.1365-313x.2001.01136.xMacho, A. P., Guevara, C. M., Tornero, P., Ruiz-Albert, J., & Beuzón, C. R. (2010). The Pseudomonas syringae effector protein HopZ1a suppresses effector-triggered immunity. New Phytologist, 187(4), 1018-1033. doi:10.1111/j.1469-8137.2010.03381.xTon, J., & Mauch-Mani, B. (2004). β-amino-butyric acid-induced resistance against necrotrophic pathogens is based on ABA-dependent priming for callose. The Plant Journal, 38(1), 119-130. doi:10.1111/j.1365-313x.2004.02028.xCANET, J. V., DOBÓN, A., ROIG, A., & TORNERO, P. (2010). Structure-function analysis of npr1 alleles in Arabidopsis reveals a role for its paralogs in the perception of salicylic acid. Plant, Cell & Environment, 33(11), 1911-1922. doi:10.1111/j.1365-3040.2010.02194.xJohnson, C. M., Stout, P. R., Broyer, T. C., & Carlton, A. B. (1957). Comparative chlorine requirements of different plant species. Plant and Soil, 8(4), 337-353. doi:10.1007/bf01666323Dobón, A., Canet, J. V., Perales, L., & Tornero, P. (2011). Quantitative genetic analysis of salicylic acid perception in Arabidopsis. Planta, 234(4), 671-684. doi:10.1007/s00425-011-1436-6Mehrtens, F., Kranz, H., Bednarek, P., & Weisshaar, B. (2005). The Arabidopsis Transcription Factor MYB12 Is a Flavonol-Specific Regulator of Phenylpropanoid Biosynthesis. Plant Physiology, 138(2), 1083-1096. doi:10.1104/pp.104.058032Konieczny, A., & Ausubel, F. M. (1993). A procedure for mapping Arabidopsis mutations using co-dominant ecotype-specific PCR-based markers. The Plant Journal, 4(2), 403-410. doi:10.1046/j.1365-313x.1993.04020403.xBell, C. J., & Ecker, J. R. (1994). Assignment of 30 Microsatellite Loci to the Linkage Map of Arabidopsis. Genomics, 19(1), 137-144. doi:10.1006/geno.1994.1023Swarbreck, D., Wilks, C., Lamesch, P., Berardini, T. Z., Garcia-Hernandez, M., Foerster, H., … Huala, E. (2007). The Arabidopsis Information Resource (TAIR): gene structure and function annotation. Nucleic Acids Research, 36(Database), D1009-D1014. doi:10.1093/nar/gkm965Jürgens G, Mayer U, Torres Ruiz RA, Berleth T, Mísera S (1991) Genetic analysis of pattern formation in the Arabidopsis embryo. Development (Supplement 1) : 27–38.Huang, W. E., Wang, H., Zheng, H., Huang, L., Singer, A. C., Thompson, I., & Whiteley, A. S. (2005). Chromosomally located gene fusions constructed in Acinetobacter sp. ADP1 for the detection of salicylate. Environmental Microbiology, 7(9), 1339-1348. doi:10.1111/j.1462-5822.2005.00821.xDeFraia, C. T., Schmelz, E. A., & Mou, Z. (2008). A rapid biosensor-based method for quantification of free and glucose-conjugated salicylic acid. Plant Methods, 4(1), 28. doi:10.1186/1746-4811-4-28Chenna, R. (2003). Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Research, 31(13), 3497-3500. doi:10.1093/nar/gkg50

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

Background Huntington's disease is caused by a CAG repeat expansion in the huntingtin gene, HTT. Age at onset has been used as a quantitative phenotype in genetic analysis looking for Huntington's disease modifiers, but is hard to define and not always available. Therefore, we aimed to generate a novel measure of disease progression and to identify genetic markers associated with this progression measure. Methods We generated a progression score on the basis of principal component analysis of prospectively acquired longitudinal changes in motor, cognitive, and imaging measures in the 218 indivduals in the TRACK-HD cohort of Huntington's disease gene mutation carriers (data collected 2008–11). We generated a parallel progression score using data from 1773 previously genotyped participants from the European Huntington's Disease Network REGISTRY study of Huntington's disease mutation carriers (data collected 2003–13). We did a genome-wide association analyses in terms of progression for 216 TRACK-HD participants and 1773 REGISTRY participants, then a meta-analysis of these results was undertaken. Findings Longitudinal motor, cognitive, and imaging scores were correlated with each other in TRACK-HD participants, justifying use of a single, cross-domain measure of disease progression in both studies. The TRACK-HD and REGISTRY progression measures were correlated with each other (r=0·674), and with age at onset (TRACK-HD, r=0·315; REGISTRY, r=0·234). The meta-analysis of progression in TRACK-HD and REGISTRY gave a genome-wide significant signal (p=1·12 × 10−10) on chromosome 5 spanning three genes: MSH3, DHFR, and MTRNR2L2. The genes in this locus were associated with progression in TRACK-HD (MSH3 p=2·94 × 10−8 DHFR p=8·37 × 10−7 MTRNR2L2 p=2·15 × 10−9) and to a lesser extent in REGISTRY (MSH3 p=9·36 × 10−4 DHFR p=8·45 × 10−4 MTRNR2L2 p=1·20 × 10−3). The lead single nucleotide polymorphism (SNP) in TRACK-HD (rs557874766) was genome-wide significant in the meta-analysis (p=1·58 × 10−8), and encodes an aminoacid change (Pro67Ala) in MSH3. In TRACK-HD, each copy of the minor allele at this SNP was associated with a 0·4 units per year (95% CI 0·16–0·66) reduction in the rate of change of the Unified Huntington's Disease Rating Scale (UHDRS) Total Motor Score, and a reduction of 0·12 units per year (95% CI 0·06–0·18) in the rate of change of UHDRS Total Functional Capacity score. These associations remained significant after adjusting for age of onset. Interpretation The multidomain progression measure in TRACK-HD was associated with a functional variant that was genome-wide significant in our meta-analysis. The association in only 216 participants implies that the progression measure is a sensitive reflection of disease burden, that the effect size at this locus is large, or both. Knockout of Msh3 reduces somatic expansion in Huntington's disease mouse models, suggesting this mechanism as an area for future therapeutic investigation